171 related articles for article (PubMed ID: 34944490)
21. Cloning and characterization of a fifth human lysyl oxidase isoenzyme: the third member of the lysyl oxidase-related subfamily with four scavenger receptor cysteine-rich domains.
Mäki JM; Tikkanen H; Kivirikko KI
Matrix Biol; 2001 Nov; 20(7):493-6. PubMed ID: 11691589
[TBL] [Abstract][Full Text] [Related]
22. Redox Potentials of Disulfide Bonds in LOXL2 Studied by Nonequilibrium Alchemical Simulation.
Lin L; Zou H; Li W; Xu LY; Li EM; Dong G
Front Chem; 2021; 9():797036. PubMed ID: 34970534
[TBL] [Abstract][Full Text] [Related]
23. Expression and purification of enzymatically active forms of the human lysyl oxidase-like protein 4.
Kim MS; Kim SS; Jung ST; Park JY; Yoo HW; Ko J; Csiszar K; Choi SY; Kim Y
J Biol Chem; 2003 Dec; 278(52):52071-4. PubMed ID: 14551188
[TBL] [Abstract][Full Text] [Related]
24. Exosomes from hypoxic endothelial cells have increased collagen crosslinking activity through up-regulation of lysyl oxidase-like 2.
de Jong OG; van Balkom BW; Gremmels H; Verhaar MC
J Cell Mol Med; 2016 Feb; 20(2):342-50. PubMed ID: 26612622
[TBL] [Abstract][Full Text] [Related]
25. Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.
de Jong OG; van der Waals LM; Kools FRW; Verhaar MC; van Balkom BWM
J Cell Physiol; 2019 Jul; 234(7):10260-10269. PubMed ID: 30387148
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis.
Aumiller V; Strobel B; Romeike M; Schuler M; Stierstorfer BE; Kreuz S
Sci Rep; 2017 Mar; 7(1):149. PubMed ID: 28273952
[TBL] [Abstract][Full Text] [Related]
27. Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1.
Kim BR; Dong SM; Seo SH; Lee JH; Lee JM; Lee SH; Rho SB
Cell Signal; 2014 Sep; 26(9):1765-73. PubMed ID: 24863880
[TBL] [Abstract][Full Text] [Related]
28. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
[TBL] [Abstract][Full Text] [Related]
29. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
30. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia.
Xu XH; Jia Y; Zhou X; Xie D; Huang X; Jia L; Zhou Q; Zheng Q; Zhou X; Wang K; Jin LP
Exp Mol Med; 2019 Feb; 51(2):1-12. PubMed ID: 30804321
[TBL] [Abstract][Full Text] [Related]
32. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.
Schilter H; Findlay AD; Perryman L; Yow TT; Moses J; Zahoor A; Turner CI; Deodhar M; Foot JS; Zhou W; Greco A; Joshi A; Rayner B; Townsend S; Buson A; Jarolimek W
J Cell Mol Med; 2019 Mar; 23(3):1759-1770. PubMed ID: 30536539
[TBL] [Abstract][Full Text] [Related]
33. LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling.
Chang J; Nicolau MM; Cox TR; Wetterskog D; Martens JW; Barker HE; Erler JT
Breast Cancer Res; 2013; 15(4):R67. PubMed ID: 23971878
[TBL] [Abstract][Full Text] [Related]
34. LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase.
Jeong C; Kim Y
Int J Mol Med; 2017 Mar; 39(3):719-724. PubMed ID: 28112368
[TBL] [Abstract][Full Text] [Related]
35. Loxl2 is dispensable for dermal development, homeostasis and tumour stroma formation.
Kober KI; Cano A; Géraud C; Sipilä K; Mobasseri SA; Philippeos C; Pisco AO; Stannard A; Martin A; Salvador F; Santos V; Boutros M; Rognoni E; Watt FM
PLoS One; 2018; 13(6):e0199679. PubMed ID: 29953488
[TBL] [Abstract][Full Text] [Related]
36. Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression.
Lu X; Xin DE; Du JK; Zou QC; Wu Q; Zhang YS; Deng W; Yue J; Fan XS; Zeng Y; Cheng X; Li X; Hou Z; Mohan M; Zhao TC; Lu X; Chang Z; Xu L; Sun Y; Zu X; Zhang Y; Chinn YE
Cancer Res; 2022 Dec; 82(23):4400-4413. PubMed ID: 36197797
[TBL] [Abstract][Full Text] [Related]
37. A tissue-specific variant of the human lysyl oxidase-like protein 3 (LOXL3) functions as an amine oxidase with substrate specificity.
Lee JE; Kim Y
J Biol Chem; 2006 Dec; 281(49):37282-90. PubMed ID: 17018530
[TBL] [Abstract][Full Text] [Related]
38. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.
Wong CC; Tse AP; Huang YP; Zhu YT; Chiu DK; Lai RK; Au SL; Kai AK; Lee JM; Wei LL; Tsang FH; Lo RC; Shi J; Zheng YP; Wong CM; Ng IO
Hepatology; 2014 Nov; 60(5):1645-58. PubMed ID: 25048396
[TBL] [Abstract][Full Text] [Related]
39. Lysyl oxidase-like 2 processing by factor Xa modulates its activity and substrate preference.
Wang H; Poe A; Martinez Yus M; Pak L; Nandakumar K; Santhanam L
Commun Biol; 2023 Apr; 6(1):375. PubMed ID: 37029269
[TBL] [Abstract][Full Text] [Related]
40. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis.
Chen W; Yang A; Jia J; Popov YV; Schuppan D; You H
Hepatology; 2020 Aug; 72(2):729-741. PubMed ID: 32176358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
